Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Net Receivables · Q4 FY2024 · quarter ended Mar 2025
Net receivables falls 62.3% from a year ago
Net receivables stood at $579.09K at the end of Q4 FY2024, down 62.3% from a year earlier.
Context
- Net receivables amounted to 10.8% of total assets at the end of Q4 FY2024, down 20.6 pp from a year earlier.
- Net receivables increased in 0 of the last 2 fiscal years.
- FY2024 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -62.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2024
- 579.09K USD
- Year-over-year change
- -62.3%
- 2-year CAGR
- -47.8%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 579.09K | -62.3% |
| FY2023 | 2024-03-31 | 1.54M | -27.7% |
| FY2022 | 2023-03-31 | 2.12M | — |
Net Receivables vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 net receivables of $579.09K is the 9th highest of the 10 companies compared; the peer median is $22.44M.
- Its year-over-year change of -62.3% is the lowest of 9, against a peer median of +4.9%.
- Net receivables amounts to 10.8% of total assets for MCTA, versus a peer median of 12.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $899.75M | -27.4% | +11.0% | 59.8% | |
| Mar 2026 | $184.05M | -21.7% | -35.6% | 40.8% | |
| Mar 2026 | $59.45M | +19.7% | +13.6% | 35.3% | |
| Mar 2026 | $38.22M | +3.6% | -7.2% | 14.0% | |
| Mar 2026 | $22.44M | -27.5% | +28.8% | 7.4% | |
| Feb 2026 | $18.17M | +10.2% | +2.0% | 12.4% | |
| Mar 2026 | $15.26M | +6.1% | +228.2% | 12.2% | |
| Mar 2026 | $5.88M | +43098.2% | -38.5% | 0.9% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $579.09K | -62.3% | — | 10.8% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MCTA) | $22.44M | +4.9% | +6.5% | 12.4% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.